We are live on ! Find out more
SGI

Summit Global Investments Portfolio holdings

AUM $1.83B
1-Year Est. Return 22.56%
This Fund
S&P 500
This Quarter Est. Return
-0.49%
1 Year Est. Return
+22.56%
3 Year Est. Return
+60.44%
5 Year Est. Return
+82.72%
10 Year Est. Return
AUM
$1.33B
AUM Growth
-$337M
Cap. Flow
-$338M
Cap. Flow %
-25.36%
Top 10 Hldgs %
26.53%
Holding
679
New
121
Increased
172
Reduced
145
Closed
216

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$301M
2
FAF icon
First American
FAF
+$12.8M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$12.1M
4
DLB icon
Dolby
DLB
+$11.6M
5
CHE icon
Chemed
CHE
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Healthcare 11.51%
3 Financials 9%
4 Consumer Discretionary 8.74%
5 Industrials 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMMR icon
451
Immersion
IMMR
$252M
$144K 0.01%
21,100
-12,800
-38% -$95.5K
SYRS
452
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$142K 0.01%
+3,180
New +$155K
CFB
453
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$140K 0.01%
+10,800
New +$143K
LTRPA
454
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$138K 0.01%
44,500
-17,500
-28% -$65.1K
INFU icon
455
InfuSystem Holdings
INFU
$249M
$136K 0.01%
+10,400
New +$170K
ALTO icon
456
Alto Ingredients
ALTO
$340M
$129K 0.01%
26,200
-20,100
-43% -$101K
AGRX
457
DELISTED
Agile Therapeutics
AGRX
$121K 0.01%
63
+8
+15% +$18.1K
RVP icon
458
Retractable Technologies
RVP
$20.1M
$110K 0.01%
+10,000
New +$117K
PRTK
459
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$90K 0.01%
+18,600
New +$103K
HARP
460
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$85K 0.01%
+1,080
New +$109K
MNKD icon
461
MannKind Corp
MNKD
$1.32B
$60K ﹤0.01%
13,901
TNXP icon
462
Tonix Pharmaceuticals
TNXP
$192M
0
AGX icon
463
Argan
AGX
$8.37B
-6,311
Closed -$302K
AIT icon
464
Applied Industrial Technologies
AIT
$13.3B
-2,403
Closed -$219K
AJG icon
465
Arthur J. Gallagher & Co
AJG
$63.6B
-13,494
Closed -$1.89M
AMT icon
466
American Tower
AMT
$80.4B
-4,661
Closed -$1.27M
APT icon
467
Alpha Pro Tech
APT
$53.1M
-68,810
Closed -$590K
ARE icon
468
Alexandria Real Estate Equities
ARE
$8.56B
-2,164
Closed -$394K
ATKR icon
469
Atkore
ATKR
$3.16B
-11,991
Closed -$851K
AVNW icon
470
Aviat Networks
AVNW
$273M
-14,300
Closed -$469K
BHF icon
471
Brighthouse Financial
BHF
$3.5B
-78,043
Closed -$3.55M
BNDX icon
472
Vanguard Total International Bond ETF
BNDX
$83.1B
-48,888
Closed -$2.79M
BRBR icon
473
BellRing Brands
BRBR
$1.34B
-24,686
Closed -$774K
BTG icon
474
B2Gold
BTG
$6.64B
-87,200
Closed -$367K
BWXT icon
475
BWX Technologies
BWXT
$15.6B
-4,400
Closed -$256K

Similar funds

Summit Global Investments's Q3 2021 Portfolio in Review

As of Q3 2021, Summit Global Investments held 679 positions worth $1.33B, down 20% from $1.67B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Summit Global Investments withdrew a net $338M in Q3 2021, closing 216 positions and reducing 145 holdings. Its most notable exit was First American, an estimated $12.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Summit Global Investments opened a new position in FedEx worth $13.2M.

  • Summit Global Investments's largest Q3 2021 buy was FedEx: 60,385 shares worth $13.2M.
  • Summit Global Investments added most to iShares Core US Aggregate Bond ETF in Q3 2021, an estimated $23.6M increase.
  • Summit Global Investments's biggest Q3 2021 reduction was Invesco QQQ Trust, cutting an estimated $301M.
  • Summit Global Investments fully exited First American in Q3 2021, selling an estimated $12.8M.
  • Summit Global Investments's ten largest holdings make up 27% of its $1.33B portfolio in Q3 2021.
  • Summit Global Investments opened 121 new positions and closed 216 in Q3 2021.
  • Summit Global Investments's portfolio value fell 20% quarter-over-quarter to $1.33B.

Based on Summit Global Investments's 13F filing for Q3 2021, filed 8 Nov 2021.